Actelion / Johnson & Johnson: Trading Idorsia, the R&D NewCo Spin-Off
J&J recent declared its tender offer for Actelion successful and we are now in the midst of the additional acceptance period which runs from...
630 Views
If Reckitt Benckiser Buys Mead Johnson Then Is a Home Care Spinoff Next?
Reckitt Benckiser Group (RB) is currently in “advanced” talks to buy Mead Johnson Nutrition Co for USD16.7 billion, in a deal that makes little...
600 Views
Cerecor's Novel Drugs for Major Depression. 'Failed' Trial or Buying Opportunity in the Stock?
We listened to Cerecor Inc (CERC US) management's conference call (link) about the phase 2 results of CERC-301 as adjunct therapy in major...
516 Views
One World, Two Stories
Celltrion's management continues to make very optimistic projections about Remsima's US sales in 2017 despite regulatory hurdles that will limit...
338 Views
Sun Pharmaceuticals: Time To Buy This World Class Pharma Company On This Pullback.
Sun Pharmaceutical Indus (SUNP IN) is the fifth largest Specialty Pharmaceuticals and Generics company in the world. It is the largest...
581 Views